IGF2BP3 and urinary bladder cancer: Wei Huang also reported that the abnormal activation of the JAK/STAT signaling pathway in bladder cancer induced by IGF2BP3, and the JAK/STAT signaling inhibitors markedly hindered the activity of IGF2BP3 [49].